compounded tirzepatide is no longer available nationwide Compounded tirzepatide expiration date: complete

Researchers followed patients for 5 years from drug initiation until onset of fibroids, loss to follow-up or September 2024, whichever came first

As patent litigation kicks off, and semaglutide nears the end of its patent exclusivity term, understanding the baseline of GLP-1 IP protections and threats is critical to ensuring a competitive edge in the market

Obesity is interlinked with mental health there are often deep-rooted reasons why people overeat

Gallbladder problems, including gallstones and cholecystitis, are associated with rapid weight loss of any cause and have been observed in clinical trials across this drug class